BACKGROUND: "Stressbusters" is an interactive computer software programme based on a clinically effective face-to-face CBT protocol for young people with depression. It was designed for teenagers with mild to moderate depression, and comprises eight 45-minute sessions. METHOD: Twenty-three young people (aged 12-16; mean age 14.87 years) with symptoms of depression were recruited from CAMHS teams in Manchester and London, and received the Stressbusters treatment (range 1 - 8 sessions, mode 8 sessions). RESULTS: On the K-SADS at initial assessment, 95% met diagnostic criteria for a depressive disorder, with a high group mean score of 35.48 (SD 9.84) on the MFQ. Post-treatment, 22% of young people met criteria for a depressive disorder, with the group mean score on the MFQ falling significantly below clinical cut-off to 20.32 (SD 11.75). These gains were maintained at 3-month follow-up. Significant improvements were also found in the adolescents' global functioning (CGAS), self-reported anxiety (RCMAS), depressive cognitions and attributions (ATQ and CTI-C), and in adolescent- and parent-reported emotional and behavioural difficulties (SDQ). CONCLUSIONS: Taken together, these results provide promising preliminary data for the clinical efficacy of Stressbusters as a valid form of CCBT for adolescents with depression.
BACKGROUND: "Stressbusters" is an interactive computer software programme based on a clinically effective face-to-face CBT protocol for young people with depression. It was designed for teenagers with mild to moderate depression, and comprises eight 45-minute sessions. METHOD: Twenty-three young people (aged 12-16; mean age 14.87 years) with symptoms of depression were recruited from CAMHS teams in Manchester and London, and received the Stressbusters treatment (range 1 - 8 sessions, mode 8 sessions). RESULTS: On the K-SADS at initial assessment, 95% met diagnostic criteria for a depressive disorder, with a high group mean score of 35.48 (SD 9.84) on the MFQ. Post-treatment, 22% of young people met criteria for a depressive disorder, with the group mean score on the MFQ falling significantly below clinical cut-off to 20.32 (SD 11.75). These gains were maintained at 3-month follow-up. Significant improvements were also found in the adolescents' global functioning (CGAS), self-reported anxiety (RCMAS), depressive cognitions and attributions (ATQ and CTI-C), and in adolescent- and parent-reported emotional and behavioural difficulties (SDQ). CONCLUSIONS: Taken together, these results provide promising preliminary data for the clinical efficacy of Stressbusters as a valid form of CCBT for adolescents with depression.
Authors: Barry Wright; Lucy Tindall; Elizabeth Littlewood; Joy Adamson; Victoria Allgar; Sophie Bennett; Simon Gilbody; Chrissie Verduyn; Ben Alderson-Day; Lisa Dyson; Dominic Trépel; Shehzad Ali Journal: BMJ Open Date: 2014-10-31 Impact factor: 2.692
Authors: Barry Wright; Lucy Tindall; Elizabeth Littlewood; Victoria Allgar; Paul Abeles; Dominic Trépel; Shehzad Ali Journal: BMJ Open Date: 2017-01-27 Impact factor: 2.692
Authors: Sarah Elisabeth Hetrick; Jo Robinson; Eloise Burge; Ryan Blandon; Bianca Mobilio; Simon M Rice; Magenta B Simmons; Mario Alvarez-Jimenez; Simon Goodrich; Christopher G Davey Journal: JMIR Ment Health Date: 2018-01-23